• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: VENITI, INC. VICI

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

VENITI, INC. VICI Back to Search Results
Model Number 26930
Device Problem Material Deformation (2976)
Patient Problem Thrombosis (2100)
Event Date 10/29/2019
Event Type  Injury  
Event Description
It was reported that the stent became occluded and stent damage occurred.The lesion was located in the common iliac vein.Two vici self expanding stents were selected for treatment and were placed.During the procedure, the 16x90x100 vici stent clotted off during the procedure.The patient was put on thrombolysis overnight.The next day, the clot was still there and the physician used a penumbra device to remove the clot.After the use of the penumbra, it was noted that the distal end of the external iliac stent was compressed and foreshortened.The physician used a balloon to open and stretch the stent.A wallstent was placed to open and extend the foreshortened stent.There were no patient complications reported.
 
Event Description
It was reported that the stent became occluded and stent damage occurred.The lesion was located in the common iliac vein.Two vici self expanding stents were selected for treatment and were placed.During the procedure, the 16x90x100 vici stent clotted off during the procedure.The patient was put on thrombolysis overnight.The next day, the clot was still there and the physician used a penumbra device to remove the clot.After the use of the penumbra, it was noted that the distal end of the external iliac stent was compressed and foreshortened.The physician used a balloon to open and stretch the stent.A wallstent was placed to open and extend the foreshortened stent.There were no patient complications reported.Additional information reported that the length of the lesion was approximately 160 cm.The area was not pre-dilated prior to stenting.Inflow was confirmed post-stenting.There were no comorbidities indicated.The physician thinks that use of penumbra to remove the clot after stent deployment caused the stent foreshortening.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VICI
Manufacturer (Section D)
VENITI, INC.
4025 clipper court
fremont CA 94538
MDR Report Key9365381
MDR Text Key167757753
Report Number2134265-2019-14203
Device Sequence Number1
Product Code QAN
Combination Product (y/n)N
PMA/PMN Number
P180013
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 12/13/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/22/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number26930
Device Catalogue Number26930
Was Device Available for Evaluation? No
Date Manufacturer Received12/10/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
PENUMBRA DEVICE; PENUMBRA DEVICE
Patient Outcome(s) Required Intervention;
-
-